Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
Datopotamab Deruxtecan 是一种新型的 TROP2 靶向抗体药物偶联物,通过高效递送药物至肿瘤细胞,展现出强大的抗肿瘤活性。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-21-0206
Okajima, Daisuke; Yasuda, Satoru; Maejima, Takanori; Karibe, Tsuyoshi; Sakurai, Ken; Aida, Tetsuo; Toki, Tadashi; Yamaguchi, Junko; Kitamura, Michiko; Kamei, Reiko; Fujitani, Tomomichi; Honda, Tomoyo; Shibutani, Tomoko; Muramatsu, Sumie; Nakada, Takashi; Goto, Riki; Takahashi, Shu; Yamaguchi, Miki; Hamada, Hirofumi; Noguchi, Yutaka; Murakami, Masato; Abe, Yuki; Agatsuma, Toshinori